Meta-analysis of Individual Patient-level Data for a Multimodal Artificial Intelligence Biomarker in High-risk Prostate Cancer: Results from Six NRG/RTOG Phase 3 Randomized Trials

Eur Urol. 2024 Oct;86(4):369-371. doi: 10.1016/j.eururo.2024.06.019. Epub 2024 Jul 17.
No abstract available

Publication types

  • Meta-Analysis

MeSH terms

  • Artificial Intelligence*
  • Biomarkers, Tumor
  • Clinical Trials, Phase III as Topic
  • Humans
  • Male
  • Prostatic Neoplasms* / pathology
  • Randomized Controlled Trials as Topic*
  • Risk Assessment
  • Risk Factors

Substances

  • Biomarkers, Tumor